title: Chemotherapy for invasive bladder cancer: facts and fallacies.
authors.affiliation: Department of Clinical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
authors.forename: D
authors.initials: D
authors.lastname: Raghavan
authors.forename: B S
authors.initials: BS
authors.lastname: Pearson
authors.forename: G J
authors.initials: GJ
authors.lastname: Coorey
authors.forename: J
authors.initials: J
authors.lastname: Boulas
authors.forename: I M
authors.initials: IM
authors.lastname: Rosen
authors.forename: H
authors.initials: H
authors.lastname: Mameghan
authors.forename: H M
authors.initials: HM
authors.lastname: Learoyd
authors.forename: P
authors.initials: P
authors.lastname: Duval
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005544:Forecasting; D006801:Humans; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D015996:Survival Rate; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000628:therapy